LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -5.9% | 188 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | -43.3% | 188 | -29.9% | 0.00% | -50.0% |
| Q1 2022 | $30,000 | -26.8% | 268 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $41,000 | +10.8% | 268 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $37,000 | +5.7% | 268 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $35,000 | -12.5% | 268 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $40,000 | +14.3% | 268 | -24.7% | 0.01% | 0.0% |
| Q4 2020 | $35,000 | – | 356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |